top of page
gradientForSurfBreak.png

Item List

Buesinesswire
COMPaSS™ Personalized Spine Surgery Study Begins Enrollment

Carlsmed® announced today that the first patients have been enrolled in the COMPaSS™ study. COMPaSS, Clinical Outcome Measures in Personalized aprevo® Spine Surgery, is a multi-center post market prospective observational registry. The study will collect data on patients with degenerative spinal conditions and are treated surgically with Carlsmed aprevo devices and will track outcomes for a period of two years.

Recent Posts

Portfolio Company

Carlsmed.png

Clario and Strados Labs partner to bring new pulmonary endpoints to respiratory ...

Strados Labs

Wavemaker 360 News

Carlsmed.png

Wavemaker Three-Sixty Health Announces 2023 Council of Strategic Advisors to Sup ...

Businesswire

Wavemaker 360 News

Carlsmed.png

MedTech Color investing in Black, brown leaders in medical technology world ...

Fox 11 News

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page